77 filings
10-Q
2024 Q2
LYEL
Lyell Immunopharma, Inc.
Quarterly report
7 Aug 24
4:10pm
8-K
LYEL
Lyell Immunopharma, Inc.
7 Aug 24
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
4:06pm
8-K
LYEL
Lyell Immunopharma, Inc.
26 Jun 24
Regulation FD Disclosure
8:32am
8-K
LYEL
Lyell Immunopharma, Inc.
14 Jun 24
Submission of Matters to a Vote of Security Holders
4:07pm
424B5
LYEL
Lyell Immunopharma, Inc.
6 May 24
Prospectus supplement for primary offering
8:12am
8-K
ymbc2 d0djyt1r8v
6 May 24
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
8:03am
EFFECT
qey0dqsmb
6 May 24
Notice of effectiveness
12:15am
ARS
5eikl pw0a33f
22 Apr 24
Annual report to shareholders
4:17pm
DEFA14A
0ilake ysp
22 Apr 24
Additional proxy soliciting materials
4:16pm
S-3
ab7jjkrgej
28 Feb 24
Shelf registration
7:49pm
S-8
416 gaduaii3
28 Feb 24
Registration of securities for employees
7:40pm
8-K
ixgliv5
28 Feb 24
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
4:07pm
8-K
0j4g4nb3n5ogy11dt86
20 Nov 23
Departure of Directors or Certain Officers
4:26pm
8-K
oxhj6u6eb9hzdix6 uq
7 Nov 23
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
4:08pm
8-K
up2w3vub3sj12ypj
11 Sep 23
Regulation FD Disclosure
9:16am